A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults

NCT07385248 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastritis

Interventions

DRUG: AD-229
DRUG: AD-2291

Sponsor

Addpharma Inc.